180 related articles for article (PubMed ID: 10541357)
1. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
Schlom J; Eggensperger D; Colcher D; Molinolo A; Houchens D; Miller LS; Hinkle G; Siler K
Cancer Res; 1992 Mar; 52(5):1067-72. PubMed ID: 1310638
[TBL] [Abstract][Full Text] [Related]
3. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
[TBL] [Abstract][Full Text] [Related]
5. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
[TBL] [Abstract][Full Text] [Related]
6. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
Chalandon Y; Mach JP; Pèlegrin A; Folli S; Buchegger F
Anticancer Res; 1992; 12(4):1131-9. PubMed ID: 1503403
[TBL] [Abstract][Full Text] [Related]
7. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
Schuster JM; Garg PK; Bigner DD; Zalutsky MR
Cancer Res; 1991 Aug; 51(16):4164-9. PubMed ID: 1714341
[TBL] [Abstract][Full Text] [Related]
8. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota T; Milenic DE; Whitlow M; Schlom J
Cancer Res; 1992 Jun; 52(12):3402-8. PubMed ID: 1596900
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.
Molthoff CF; Pinedo HM; Schlüper HM; Rutgers DH; Boven E
Int J Cancer; 1992 Apr; 51(1):108-15. PubMed ID: 1563830
[TBL] [Abstract][Full Text] [Related]
11. WR2721 protection of bone marrow in 131I-labeled antibody therapy.
Badger CC; Rasey J; Nourigat C; Fisher DR; Hui TE; Wu ZM; Bernstein ID
Radiat Res; 1991 Dec; 128(3):320-4. PubMed ID: 1660165
[TBL] [Abstract][Full Text] [Related]
12. The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo.
Langmuir VK; Mendonca HL
Radiat Res; 1992 Dec; 132(3):351-8. PubMed ID: 1475358
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.
Bender H; Takahashi H; Adachi K; Belser P; Liang SH; Prewett M; Schrappe M; Sutter A; Rodeck U; Herlyn D
Cancer Res; 1992 Jan; 52(1):121-6. PubMed ID: 1727372
[TBL] [Abstract][Full Text] [Related]
14. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography.
Roberson PL; Buchsbaum DJ; Heidorn DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 1992; 24(2):329-34. PubMed ID: 1526872
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy for liver micrometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
Saga T; Sakahara H; Nakamoto Y; Sato N; Zhao S; Iida Y; Kuroki M; Endo K; Konishi J
Jpn J Cancer Res; 1999 Mar; 90(3):342-8. PubMed ID: 10359050
[TBL] [Abstract][Full Text] [Related]
17. Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Matthews DC; Badger CC; Fisher DR; Hui TE; Nourigat C; Appelbaum FR; Martin PJ; Bernstein ID
Cancer Res; 1992 Mar; 52(5):1228-34. PubMed ID: 1531324
[TBL] [Abstract][Full Text] [Related]
18. [Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential].
Mach JP; Pèlegrin A; Folli S; Buchegger F
Bull Acad Natl Med; 1992 Jun; 176(6):879-89. PubMed ID: 1464034
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled antibody targeting of the HER-2/neu oncoprotein.
De Santes K; Slamon D; Anderson SK; Shepard M; Fendly B; Maneval D; Press O
Cancer Res; 1992 Apr; 52(7):1916-23. PubMed ID: 1348016
[TBL] [Abstract][Full Text] [Related]
20. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
